Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of AhR agonist for the preventive or curative treatment of metabolic syndrome and the associated disorders

Use of AhR agonist for the preventive or curative treatment of metabolic syndrome and the associated disorders

US Patent 11596657 · Granted Mar 7, 2023

Estimated economic value: $446,628,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Diagnosis, prognosis and treatment of a disease related to a decrease of F. prau2025
Nutritional composition comprising 2′-Fucosyllactose (2′ FL) to improve the gast2025
Faecalibacterium prausnitzii strains for treating and preventing gastrointestina2023
Faecalibacterium prausnitzii strains for treating and preventing gastrointestina2023
Probiotic strain of Lactobacillus brevis2022
Probiotic composition comprising Lactobacillus rhamnosus and Lactobacillus parac2021
Bacterial strain as agents for preventing and/or treating respiratory disorders2021
Compositions for the inhibition of Giardia lamblia2021
Anti-inflammatory peptides and methods for treating inflammatory diseases2021
Anti-inflammatory peptides and methods for treating inflammatory diseases2021
Faecalibacterium prausnitzii strain CNCM 1-4573 for the treatment and prevention2021
Faecalibacterium prausnitzii strain CNCM 1-4573 for the treatment and prevention2021